Clinical Trial Update: Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention and treatment of chemotherapy-induced nausea and vomiting in gynecologic cancer patients treated with the TC regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Gynecological Tumor, Ovarian Cancer | Phase 3 | Status: COMPLETED